Philip Liang - Mar 17, 2022 Form 4 Insider Report for Vicarious Surgical Inc. (RBOT)

Role: Director
Signature: /s/ June Morris, Attorney-in-Fact
Stock symbol: RBOT
Transactions as of: Mar 17, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/21/2022, 07:14 PM
Previous filing: Mar 4, 2022
Next filing: Mar 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RBOT	Class A Common Stock	Other	$0	-266K	-11.13%	$0.00	2.12M	Mar 17, 2022	By Chelvey International Limited	F1, F2
transaction	RBOT	Class A Common Stock	Award	$0	+266K	+744.88%	$0.00	302K	Mar 17, 2022	Direct	F1, F3
holding	RBOT	Class A Common Stock						300K	Mar 17, 2022	By E15 Fund Advisors (HK) Limited	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partner, Mr. Liang, on a pro rata basis, for no consideration.
F2	Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
F3	Consists of (i) 265,990 shares of Class A Common Stock held by Mr. Liang and (ii) 35,709 restricted stock units ("RSUs") held by Mr. Liang. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Liang's continued service through the applicable vesting date.
F4	Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.